OS Fund

Venture Capital

Venture fund founded by Bryan Johnson investing in companies working on the operating systems of life, including synthetic biology, genomics, and AI.

Profile

Founded
2014
Headquarters
New York, US
Investments
3
Companies
2

Capital

Total Deployed
$60M
Lead Rounds
0

Portfolio

2 companies
Ginkgo Bioworks $720M
Public Boston, US

Synthetic biology company that builds an automated platform for programming cells, enabling customers across pharmaceuticals, agriculture, and industrial chemicals to harness the power of biology.
Notable Labs $66M
Private Foster City, United States

Clinical-stage precision oncology company that built a proprietary Predictive Precision Medicines Platform (PPMP) to bio-simulate cancer treatments and predict patient response. Originally tested combinations of FDA-approved drugs on patient cancer cell samples for blood cancers. Demonstrated 84% accuracy in predicting treatment responses with Stanford.

Investment data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.